Henan Lihua Pharmaceutical Co., Ltd

About Us


Henan Lihua Pharmaceutical Co., Ltd. was established in 1994, located at Middle of Huanghe Street, Anyang High-tech Industry Development Zone, Henan, China. The total area is 93,000m2. Henan Lihua is a leading National High-tech Enterprise and Custom AA management enterprise integrating R&D, production and sales of steroids active pharmaceutical ingredients (APIs) and intermediates. And Henan Lihua has more than 500 employees.

The product portfolio comprises Prednisolone, Prednisone, Cortisone, Betamethasone and their derivatives, 6 series of more than 50 varieties. These products also meet the following pharmacopeia specifications: Ph.Eur., USP, JP, IP and ChP. Products are presently sold to almost 60 countries in Europe, North and South America, Asia and Africa. Henan Lihua has completed 11 product approvals for domestic API registration and obtained 7 CEP certificates issued by EDQM. Henan Lihua successfully passed site inspection of US FDA by 0 483 and obtained CEP of Clobetasol propionate issued by EDQM without observations. Pfizer of United States, Aceto of Germany, Sanofi of France and other international famous pharmaceutical companies are our long-term and stable important customers.

Attach great importance to product R&D, we have spent more than RMB 50 million on R&D in the past three years. Henan Lihua has carried out 18 R&D projects, obtained 33 scientific and technological achievements through independent R&D, and converted more than 9 scientific and technological achievements on average every year. The company has scientific research platforms such as Henan Provincial Enterprise Technology Center, Henan Province Glucocorticoid Engineering Technology Research Center and Provincial and Municipal Steroids Engineering Research Center, and has authorized 28 patents, including 20 invention patents and 8 utility model patents. In cooperation with the Institute of Process Engineering, Chinese Academy of Sciences, Henan Lihua has developed a series of green solvent-ionic liquid products, which are in the forefront of the world and have broad industrial development prospects.  

The annual sales revenue is RMB 500 million, the annual export income is more than 50 million dollars, and the annual tax is more than RMB 20 million. Henan Lihua has made a positive contribution to the economic development of Anyang, become an important new force of steroids industry in the domestic and overseas.

To accomplish our mission “To be dedicated to corticosteroid substance research and application, meet with customers' demands with exceptional products and service, and constantly enhance human living quality”, Henan Lihua has always been adhering to the "Customer First, Technology-based, Honesty and Pragmatic, Harmony and Win-win" core values, strengthen to construct an EHS system proactively for the sake of a safety, environmental protection and sustainable development of the company.

Looking forward to the future, Henan Lihua Pharmaceutical Co., Ltd. is heading for the enterprise vision goal of "becoming the leader in the world steroids industry", striving hard and forging ahead.